EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CDT

CDT

CDT Equity Inc.

Next earnings Jun 26, 2026

Hold
$0.64
▼ -10.81%
$0.64▼ -99.86%
over 1Y
L $0.64EODHDH $584.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-10.8%
1W-57.6%
1M-42.2%
3M-91.9%
YTD-98.2%
1Y-99.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
F
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)

High return on equity (547.1%).

Return on equity 547.1% · latest

CDT Equity Inc. shows limited reported revenue, and 547.1% ROE.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue————
Gross profit————
Operating income-$3.16M-$5.26M-$15.4M-$36.8M
Net income-$4.89M-$535K-$17.8M-$39.2M
Diluted EPS-$0.13-$8.92-$61,598.62-$1,177.89
Net margin————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.58M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-1269.4%
FCF yield-505.1%

Quality & risk

ROIC (est.)—
Free cash flow-$15.6M
Total debt—
Net cash$1.51M
Piotroski F-Score3/6

Capital returns

Buyback yield3.4%
Dividend yield (est.)—
Shareholder yield3.4%
Shares Δ YoY-27.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-05-28). Worth a closer look.
  1. 8-K Material agreement2026-06-16
  2. 8-K Delisting notice2026-05-28
  3. 8-K Material agreement2026-05-15
  4. NT 10-Q Late filing notice2026-05-15
  5. 8-K Officer / director change2026-04-27
  6. S-3 Shelf registration (potential raise)2026-04-22
  7. 10-K Annual report2026-04-15
  8. NT 10-K Late filing notice2026-04-01
  9. 8-K Material event2026-03-25

Recent filings

all on EDGAR ↗
SCHEDULE 13D/AFiling2026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗8-KPeriod ending 2026-06-112026-06-16open ↗SCHEDULE 13GFiling2026-06-05open ↗8-KPeriod ending 2026-05-212026-05-28open ↗SCHEDULE 13GFiling2026-05-20open ↗NT 10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-05-152026-05-15open ↗SCHEDULE 13D/AFiling2026-05-14open ↗4Period ending 2026-03-242026-05-14open ↗EFFECTFiling2026-05-01open ↗424B3Filing2026-05-01open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
GrowthF
Profitability—
Financial healthF
Momentum—
  • ✗Profitable (positive net income)
  • ✓Liabilities below 2× equity
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

■ revenue · ■ net income, by fiscal year

Net income-$39.2M-120.3%
Operating income-$36.8M-138.4%
Diluted EPS-$1,177.89+98.1%
Cash & equivalents$1.51M+172.4%
Total assets$5.65M+34.7%
Total liabilities$12.8M+16.7%
Stockholders' equity-$7.17M-5.5%
L/E: -1.79x

Frequently asked

Is CDT Equity Inc. (CDT) a buy?
CDT currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (547.1%).
What is CDT Equity Inc.'s quality score?
CDT scores 18.999999999999996/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001896212, latest 10-K filed 2026-04-15) · EODHD · as of 6/20/2026, 7:40:45 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 4 sales

2026-06-18
Taylor Mark Andrew
10% owner
Sell5.00K @ $0.71$3.53K
2026-06-18
Taylor Mark Andrew
10% owner
Sell1.46M @ $1.44$2.11M
2026-06-18
Taylor Mark Andrew
10% owner
Sell5.00K @ $0.75$3.75K
2026-06-18
Taylor Mark Andrew
10% owner
Sell593K @ $1.40$829K
2026-05-13
Regan Andrew
Chief Executive Officer
Award100K @ $1.90$190K
2026-03-24
Regan Andrew
Chief Executive Officer
Award147K
2026-03-17
Taylor Mark Andrew
10% owner
Acquired (J)51.4M
2026-02-19
Taylor Mark Andrew
10% owner
Disposed (J)46.9K
2026-02-19
Farley Chele Chiavacci
Director
Award10.6K @ $1.04$11.0K
2025-12-08
Regan Andrew
Chief Executive Officer
Award225K @ $1.79$402K
2025-09-19
Regan Andrew
Chief Executive Officer
Award1.12M @ $0.69$769K
2025-09-19
Bligh James
CFO
Award480K

Recent news

market news →
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form DevelopmentBullish
globenewswire.com· 2026-06-26
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency LetterBullish
finance.yahoo.com· 2026-05-28
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency LetterBullish
globenewswire.com· 2026-05-28
CDT Announces Canadian Patent for AZD5904 in Male InfertilityBullish
finance.yahoo.com· 2026-05-27
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection StageBullish
finance.yahoo.com· 2026-05-11
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering DiscussionsBullish
finance.yahoo.com· 2026-05-06

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score19 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 5d
Bullish
+0.15
vs typical · 6 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.